Background: Psoriasis is a chronic immune-mediated inflammatory disease, and a mixed Th1/Th17 cytokine environment plays a critical role in the pathogenesis of psoriasis. Dermal fibroblasts secrete certain cytokines such as IL-6, IL-8, and CXCL-1, contributing to the hyperproliferative state of the epidermis in psoriatic skin. Ultraviolet B (UVB) phototherapy is one of the most commonly used treatments in psoriasis but the influence of UVB on human dermal fibroblasts (HDFs) in psoriasis treatment is not completely understood.
inTrODUcTiOn Psoriasis is a chronic immune-mediated inflammatory disease with complex cytokines network and diverse cellular participation, which mainly includes T lymphocytes, keratinocytes, neutrophils, antigen presenting cells, even fibroblasts, and so on. A mixed Th1/Th17 cytokine environment plays a critical role in the pathogenesis of psoriasis (1) . TNF-α is a key cytokine in the development of psoriasis, and most psoriatic patients have a positive response to the anti-TNF biologics. TNF-α alone does not induce significant response from cultured keratinocytes; however, TNF-α combined with IL-17A forms intense synergies and amplifies the inflammatory reaction (2) .
Fibroblasts are the principal cells of the dermis and emerging as an important player in inflammation (3) . Dermal fibroblasts can secrete insulin-like growth factor-I that contribute to the epidermal hyperplasia of psoriasis by promoting keratinocyte proliferation (4) . Dermal fibroblasts can also secrete certain cytokines such as IL-6, IL-8, and CXCL-1, which contribute to the hyperproliferative state of the epidermis in psoriatic skin, and these cytokines production in fibroblasts would increase via interaction with neutrophils or normal/malignant epithelial cells, or incubation in the presence of TNF-α or white adipocytessecreted leptin (5) (6) (7) (8) . As one of the most important cytokines in psoriasis, IL-17A increases IL-8 and MCP-1 production in a dose-dependent manner in human dermal fibroblasts (HDFs) both at protein and mRNA levels, and there exists synergistic activity between IL-17A and TNF-α (9) .
Ultraviolet B (UVB) irradiation mainly affects the epidermis and the superficial dermis. UVB phototherapy is one of the oldest and most commonly used treatments in psoriasis, including heliotherapy, broadband UVB, narrowband UVB, and excimer laser (10) . It is generally recognized that UVB has an immunosuppressive effect on the skin. UVB induces lymphocyte apoptosis and alleviates psoriasis via the upregulation of regulatory T cells (11) . Additionally, UVB treatment causes a marked reduction in the expression of skin-homing molecules by circulating T cells (12) .
However, the influence of UVB on HDFs potently involved in the pathogenesis of psoriasis is not completely understood in psoriasis phototherapy. Hence, we conducted this study to mimic a psoriatic microenvironment in order to investigate and illustrate the combined effects of UVB, IL-17A, and TNF-α on HDFs.
MaTerials anD MeThODs ethics statement
This study was carried out in accordance with the recommendations of institutional guidelines and Local Ethics Committee of the First Affiliated Hospital of Nanjing Medical University with written informed consent from all subjects.
cell culture for hDFs
The foreskins of healthy adult (age range 18-60 years) were the source of HDFs. HDFs were isolated and cultured as previously described (13) . Circumcised prepuce samples were obtained in accordance with the ethical committee approval process of Jiangsu Province Hospital. All subjects gave written informed consent in accordance with the Declaration of Helsinki. HDFs used for experiments were in the second or third passage.
Treatment of hDFs
Recombinant human IL-17A (100 ng/ml), TNF-α (10 ng/ml), and TGF-β1 (2 ng/ml) were obtained from PEPROTECH (Rocky Hill, NJ, USA), and P144 (2 µg/ml) was purchased from MedChem Express (Monmouth Junction, NJ, USA). The source of UVB was a BLE-1T158 UV lamp (Spectronics Corp., Westbury, NY, USA). The UVB dosage (30 mJ/cm 2 ) was quantified using a Waldmann UV meter (model number 585,100; Herbert Waldmann GmbH & Co., KG, Villingen-Schwenningen, Germany). The HDFs were seeded in 6-well culture plates and incubated for 24 h. Experiments were repeated independently at least three times.
real-time Quantitative Pcr
After 24 h of incubation, the supernatant was collected, and the HDFs attached to the culture plates were washed three times using PBS and then dissolved in TRIzol ® reagent (Invitrogen; Life Technologies Corp., Carlsbad, CA, USA), and total RNA was isolated. First-strand cDNA was synthesized from 2 µg of total RNA: RNA was incubated at 42°C for 1 h with M-MuLV Reverse Transcriptase (Thermo Fisher Scientific Inc., Waltham, MA, USA) following oligo(dT) priming, and then the enzyme was denatured at 70°C for 10 min. PCR amplification was performed in a total volume of 20 µl containing 1 µl template cDNA, and transcripts quantified using StepOnePlus™ Real-Time PCR System (Applied Biosystems, USA). All values were normalized to the expression of the housekeeping gene GAPDH. Primer sequences are shown in Table 1 .
Western Blot for il-6, il-8, cXcl-1, and smad3 expression of hDFs After 24 h, the HDFs were washed and then lysed in RIPA buffer containing protease inhibitor. Centrifugal separation was UVB Inhibits IL-17A/TNF-α-Induced HDFs Activation Flow cytometry for Detection of the surface expression of il-17ra and il-17rc on hDFs
Detection of IL-17RA and IL-17RC expression were performed using human IL-17RA-FITC and IL-17RC-FITC antibodies (Miltenyi Biotec, Bergisch Gladbach, Germany). HDFs were fixed with 70% alcohol, washed twice with PBS, digested with RNase, and stained with propidium iodide. A flow cytometer (FAC-Scan, BD, NJ, USA) was used to gather data and images.
Tissue culture and immunohistochemistry
Three individuals with chronic plaque psoriasis were enrolled (age range 18-60 years). Inclusion criteria included no systemic antipsoriatic treatments for 1 month before biopsy. Biopsies were taken from psoriatic plaques. All subjects gave written informed consent according to the Declaration of Helsinki. The subdermal tissue was removed by scraping with forceps, and each tissue cut into two pieces of 0.5-1.0 cm, and then cultured dermal side down in 1 ml RPMI with 10% fetal bovine serum, 55 mM β-mercaptoethanol, 2 mM glutamine, 100 µg/ml streptomycin, and 100 U/ml penicillin per well of 12-well culture plate for 24 h (14). The epidermis was kept above the medium surface. Then, 60 mJ/cm 2 of UVB was irradiated once to the epidermal side of the tissues before culture.
After 24 h, the tissues were collected and formalin fixed and paraffin embedded for immunohistochemical staining. Slides were prepared using a Ventana autoimmunostainer (Loche, USA) and available IL-6, IL-8 antibodies (Proteintech, Wuhan, Hubei, China) and CXCL-1 antibody (Bioworld, Nanjing, Jiangsu, China).
The numbers of typical staining positive fibroblasts were counted for five successive fields in high magnification (HM, ×400). The number of cells was calculated and expressed as the numbers of Positive fibroblasts/HM.
statistical analysis
GraphPad Prism for Windows (GraphPad Software, San Diego, CA, USA) was used for data analysis. All data are presented as mean ± SD. Data were tested for normality and statistical significance calculated using a Student's t-test, Mann-Whitney U test, or Friedman's test, as appropriate. Significance was defined as P < 0.05. resUlTs il-17a/TnF-α stimulation have additive or synergistic effect on Pro-inflammatory cytokines and chemokines expression by hDFs
We stimulated HDFs with IL-17A and TNF-α alone or together, which showed both IL-17A and TNF-α induced significant increases in IL-6, IL-8, and CXCL-1 mRNA expression (P < 0.05; Figure 1 ). In addition, synergistic (IL-6 and IL-8) and additive (CXCL-1) effect of IL-17A/TNF-α stimulation on HDFs were seen. Our study also showed IL-17A induced the mRNA expression of TNFR-2 and TNF-α induced IL-17RA and IL-17RC expression on HDFs (P < 0.05; Figure 1 ).
hDFs Produce significant il-6, il-8, and cXcl-1 in response to il-17a/TnF-α stimulation and UVB irradiation
We stimulated HDFs with IL-17A/TNF-α and observed statistically significant increases in IL-6, IL-8, and CXCL-1 mRNA. Treatment of HDFs with UVB irradiation also led to marked mRNA expression of IL-6, IL-8, and CXCL-1 (P < 0.01; Figure 2A ). The increase in IL-6, IL-8, and CXCL-1 was further confirmed at the protein level (Figures 3A,B) . Although Western blot of cell lysates did not show significant increase in IL-8 protein in UVB group, ELISA analysis of supernatant confirmed the IL-8 protein secretion. HDFs irradiated with UVB followed by IL-17A/TNF-α stimulation expressed significantly less IL-6, IL-8, and CXCL-1 mRNA compared with single IL-17A/TNF-α treatment (P < 0.01; Figure 2A ), which was also confirmed at the protein level (Figures 3A,B) . Similarly, Western blot did not show significant decrease in IL-6 and CXCL-1 protein in IL-17A/ TNF-α + UVB group compared with IL-17A/TNF-α group, but ELISA analysis confirmed the significant difference of protein secretion.
The inhibitory effect of UVB on il-17a/ TnF-α-stimulated activation of hDFs is through Decreasing the expression of il-17ra and il-17rc on Fibroblasts
We investigated the expression of TNFR-1, TNFR-2, IL-17RA, and IL-17RC mRNA, which showed IL-17A/TNF-α stimulation increased the mRNA expression of TNFR-2, IL-17RA, and IL-17RC by HDFs and UVB irradiation increased the expression of TNFR-1 and TNFR-2 (P < 0.01; Figure 2A ) but decreased IL-17RA and IL-17RC expression (P < 0.05; Figure 2A ). IL-17A/TNF-α combined with UVB treatment had synergistic effect on TNFR-1 and TNFR-2 mRNA expression 2 ), and TgF-β1 (2 ng/ml) for 24 h. (a) IL-17A/TNF-α-stimulated HDFs increase expression of IL-6, IL-8, and CXCL-1 mRNA, which are also seen in 30 mJ/cm 2 UVB-irradiated HDFs. But UVB irradiation inhibits IL-17A/TNF-α-induced IL-6, IL-8, and CXCL-1 mRNA expression of HDFs. IL-17A/TNF-α stimulation induce the expression of TNFR-2, IL-17RA, and IL-17RC mRNA. UVB irradiation upregulates the expression of TNFR-1 and TNFR-2 mRNA but downregulates IL-17RA and IL-17RC expression, and inhibits IL-17A/TNF-α-induced IL-17RA and IL-17RC mRNA expression. IL-17A/TNF-α and UVB treatment do not induce significant expression of TGF-β1 mRNA 24 h after culture, but Smad3 mRNA is upregulated in both UVB irradiation and IL-17A/TNF-α + UVB groups. (B) TGF-β1 significantly induces the Smad3 mRNA expression and downregulates the IL-17RA and IL-17RC expression in HDFs. The data (fold change) are from one representative experiment performed in triplicate, repeated three times with similar results. UVB, ultraviolet B; HDFs, human dermal fibroblasts. Statistical significance indicated: *P < 0.05, **P < 0.01, ***P < 0.001. FigUre 1 | real-time quantitative Pcr analyses of hDFs stimulated with il-17a (100 ng/ml) and TnF-α (10 ng/ml) alone or together for 24 h. The results demonstrate that both il-17a and TnF-α induce significant increases in il-6, il-8, and cXcl-1 mrna expression and il-17a/TnF-α stimulation have additive or synergistic effect on il-6, il-8, and cXcl-1 mrna expression. Additionally, IL-17A induces the mRNA expression of TNFR-2 and TNF-α induces IL-17RA and IL-17RC expression on HDFs. The data (fold change) are from one representative experiment performed in triplicate, repeated three times with similar results. HDFs, human dermal fibroblasts. Statistical significance indicated: *P < 0.05, **P < 0.01, ***P < 0.001. Other data are from one representative experiment performed in triplicate, repeated three times with similar results. UVB, ultraviolet B; HDFs, human dermal fibroblasts. Statistical significance indicated: *P < 0.05, **P < 0.01, ***P < 0.001. of unirradiated psoriatic plaque lesion. In UVB irradiation group, there were less staining positive fibroblasts (P < 0.05; Figure 5 ).
DiscUssiOn
As the key cytokines in the pathogenesis of psoriasis, IL-17A can synergize with TNF-α to induce the production of MCP-1, IL-8, and MMP-1 by dermal fibroblasts (9) . Our study proved IL-17A (100 ng/ml) and TNF-α (10 ng/ml) stimulation had synergistic or additive effect on the expression of IL-6, IL-8, and CXCL-1 mRNA and protein by HDFs. IL-6, IL-8, and CXCL-1 play active roles in the development of psoriasis (6) . On the other hand, HDFs subjected to UVB irradiation induce significant TNF-α, IL-6, and IL-8 production (15, 16) . All together, we speculated prior to the onset of our experiment that there might be additive or synergistic effect of IL-17A/TNF-α stimulation combined with UVB irradiation on pro-inflammatory cytokines and chemokines expression by HDFs. Interestingly, our HDFs study showed that there was no synergy between IL-17A/TNF-α and UVB, and unexpectedly UVB significantly inhibited IL-17A/TNF-α-induced IL-6, IL-8, and CXCL-1 expression by HDFs, which were confirmed at both gene and protein levels. IL-17A signals through a receptor complex composed of IL-17RA and IL-17RC, which are expressed on keratinocytes, endothelial cells, fibroblasts, and so on (17) . TNFR-1 (p55) and TNFR-2 (p75) on dermal fibroblasts are involved in TNF-α-mediated DNA synthesis and IL-6 and IL-8 release (18) . TNF-α has the ability to increase the expression of IL-17R by UVB (30 mJ/cm 2 ) irradiation induces significant TgF-β1 Protein secretion and expression of smad3 mrna and Protein by hDFs IL-17A/TNF-α and UVB (30 mJ/cm 2 ) did not induce significant expression of TGF-β1 mRNA 24 h after treatment (Figure 2A) , but ELISA analysis showed significant TGF-β1 protein secretion in supernatant in both UVB and IL-17A/TNF-α + UVB groups compared with Control group (P < 0.01; Figure 4A ). The mRNA and protein expression of Smad3 were simultaneously upregulated in both UVB and IL-17A/TNF-α + UVB groups (P < 0.05; Figures 2A and 4B) .
We used recombinant human TGF-β1 (2 ng/ml) to stimulate HDFs for 24 h, which showed TGF-β1 significantly induced the Smad3 mRNA expression and downregulated the IL-17RA and IL-17RC expression on HDFs (P < 0.01; Figure 2B ). We also observed P144 (anti-TGF-β1) blocked the inhibitory effect of UVB on the expression of IL-17RA and IL-17RC on fibroblasts (P < 0.05; Figure 4C ).
UVB (60 mJ/cm
2 ) irradiation Decreases the expression of il-6, il-8, and cXcl-1 in Dermal Fibroblasts of Psoriatic Plaques keratinocytes and IL-17A to induce TNFR expression, and short hairpin RNA inhibition of IL-17R expression abrogates synergistic gene induction by TNF-α and IL-17A (1, 19) . Human primary lung fibroblasts stimulated with TNF-α expressed increased mRNA levels of IL-17BR (IL-17RA-IL-17RB complex) (20) . UVB induces the expression of TNFR-1 and TNFR-2 on murine fibroblasts in a dose-dependent manner (21) . Our study observed TNF-α and IL-17A mutually induced the mRNA expression of another cytokine's receptor on HDFs and IL-17A/TNF-α-stimulated HDFs had significant elevated mRNA expression of TNFR-2, IL-17RA, and IL-17RC. We also found that UVB irradiation increased the expression of TNFR-1 and TNFR-2 on HDFs, which was consistent with the findings on murine fibroblasts (21) . Additionally, IL-17A/TNF-α and UVB had synergistic effect on mRNA expression of TNFR-1 and TNFR-2 of HDFs. The effect of UVB irradiation on IL-17RA and IL-17RC of HDFs was interesting, where the mRNA and protein expression of IL-17RA and IL-17RC markedly decreased after low-dose UVB irradiation. Based on the above findings, we presumed that UVB suppressed IL-17RA and IL-17RC expression in HDFs, blunting the strong synergy between IL-17A and TNF-α, which contributed to decreased IL-6, IL-8, and CXCL-1 expression by HDFs.
TGF-β1 downregulated the expression of IL-17BR mRNA on human primary lung fibroblasts (20) . Nakashima et al. reported ectopic TGF-β1 stimulation significantly downregulated the IL-17RA expression in normal fibroblasts and the effect of TGF-β1 on IL-17RA was Smad3 dependent (22) . Our study confirmed TGF-β1-stimulated HDFs significantly upregulated Smad3 mRNA and downregulated IL-17RA and also IL-17RC, indicating that IL-17RA and IL-RC expression may be regulated by TGF-β1/Smad3 signaling pathway. The effect of UVB irradiation on TGF-β1 expression of HDFs depends on the dose of irradiation and observing time after treatment. HDFs were given 10 exposures to UVB at 250 mJ/cm 2 (twice a day for 5 days) and TGF-β1 expression was significantly increased after the last stress (23). Then, 144 mJ/cm 2 of UVB-irradiated HDFs secreted significantly less TGF-β1 protein 72 h after treatment compared with unirradiated cells (24) . Choi et al. reported after irradiation with 25 mJ/cm 2 UVB on HDFs, TGF-β1 mRNA significantly decreased at 24 and 48 h (25). Cao et al. investigated the expression of TGF-β1 mRNA in HDFs at various time points after 10 mJ/cm 2 UVB irradiation and found TGF-β1 mRNA was increased 4 and 8 h after UVB irradiation and gradually decreased and reached the control level at 24 h, additionally, ELISA analysis showed TGF-β1 protein in the supernatant was increased 12 h after 10 mJ/cm 2 UVB irradiation (26). Our study found there was no significant difference in the expression of TGF-β1 mRNA between 30 mJ/cm 2 UVB-irradiated and unirradiated HDFs 24 h after treatment, but ELISA analysis of TGF-β1 showed significant increase in protein secretion of UVB irradiation group, indicating the increase in TGF-β1 mRNA expression after 30 mJ/cm 2 UVB irradiation happens within 24 h. P144, a TGF-β1 antagonist peptide (27) , was proved to be able to block the inhibition of UVB irradiation on the expression of IL-17RA and IL-17RC on HDFs. As above, the effect of UVB irradiation on HDFs seems to be changeable in different conditions, and low-dose UVB usually used for phototherapy has transient action on HDFs to induce TGF-β1 production and then inhibits the expression of IL-17RA and IL-17RC through TGF-β1/Smad3 signaling pathway.
IL-17A and TNF-α play key roles in the complex inflammatory network of psoriasis, promoting immune activation, and the maintenance of psoriasis lesions. Therapeutic options for psoriasis mainly include topical and systemic medications, biologic agents, and phototherapy. Phototherapy remains one of the most effective and safest model of treatment for psoriasis, especially UVB (10, 28) . Our results confirm that UVB irradiation inhibits IL-17A/TNF-α-induced IL-6, IL-8, and CXCL-1 production in HDFs by decreasing the expression of IL-17RA and IL-17RC on fibroblasts through TGF-β1/Smad3 pathway, which reveals a new mechanism of the therapeutic action of UVB on psoriasis. Further investigation focusing on the effect of UVB irradiation on dermal fibroblasts isolated from psoriatic patients would be informative and necessary. The modes of action by which TNF-α and IL-17A mutually induce the expression of another cytokine's receptor and UVB induces TNFR-1 and TNFR-2 expression on HDFs remains to be elucidated. 
